These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23910585)

  • 1. Relationship of myocardial fibrosis to left ventricular and mitochondrial function in nonischemic dilated cardiomyopathy--a comparison of focal and interstitial fibrosis.
    Yamada T; Hirashiki A; Cheng XW; Okumura T; Shimazu S; Okamoto R; Shinoda N; Isobe S; Takeshita K; Naganawa S; Kondo T; Murohara T
    J Card Fail; 2013 Aug; 19(8):557-64. PubMed ID: 23910585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study.
    Masci PG; Schuurman R; Andrea B; Ripoli A; Coceani M; Chiappino S; Todiere G; Srebot V; Passino C; Aquaro GD; Emdin M; Lombardi M
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):790-9. PubMed ID: 23934992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
    Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
    Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fat deposition in dilated cardiomyopathy assessed by CMR.
    Lu M; Zhao S; Jiang S; Yin G; Wang C; Zhang Y; Liu Q; Cheng H; Ma N; Zhao T; Chen X; Huang J; Zou Y; Song L; He Z; An J; Renate J; Xue H; Shah S
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):889-98. PubMed ID: 23850250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in children and adolescents with dilated cardiomyopathy.
    Latus H; Gummel K; Klingel K; Moysich A; Khalil M; Mazhari N; Bauer J; Kandolf R; Schranz D; Apitz C
    J Cardiovasc Magn Reson; 2015 May; 17(1):34. PubMed ID: 25976093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of discrepant mid-wall late gadolinium enhancement in patients with nonischemic dilated cardiomyopathy.
    Ehara S; Matsumoto K; Kitada R; Nishimura S; Shimada K; Yoshiyama M
    Heart Vessels; 2018 Dec; 33(12):1482-1489. PubMed ID: 29804280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of myocardial deformation with cardiac magnetic resonance strain imaging improves risk stratification in patients with dilated cardiomyopathy.
    Buss SJ; Breuninger K; Lehrke S; Voss A; Galuschky C; Lossnitzer D; Andre F; Ehlermann P; Franke J; Taeger T; Frankenstein L; Steen H; Meder B; Giannitsis E; Katus HA; Korosoglou G
    Eur Heart J Cardiovasc Imaging; 2015 Mar; 16(3):307-15. PubMed ID: 25246506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased (99m)Tc-sestamibi washout reflects impaired myocardial contractile and relaxation reserve during dobutamine stress due to mitochondrial dysfunction in dilated cardiomyopathy patients.
    Hayashi D; Ohshima S; Isobe S; Cheng XW; Unno K; Funahashi H; Shinoda N; Okumura T; Hirashiki A; Kato K; Murohara T
    J Am Coll Cardiol; 2013 May; 61(19):2007-17. PubMed ID: 23501381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of myocardial fibrosis on left ventricular torsion and twist in patients with non-ischemic dilated cardiomyopathy.
    Karaahmet T; Gürel E; Tigen K; Güler A; Dündar C; Fotbolcu H; Basaran Y
    Cardiol J; 2013; 20(3):276-86. PubMed ID: 23788302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy.
    aus dem Siepen F; Buss SJ; Messroghli D; Andre F; Lossnitzer D; Seitz S; Keller M; Schnabel PA; Giannitsis E; Korosoglou G; Katus HA; Steen H
    Eur Heart J Cardiovasc Imaging; 2015 Feb; 16(2):210-6. PubMed ID: 25246502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects.
    Hong YJ; Park CH; Kim YJ; Hur J; Lee HJ; Hong SR; Suh YJ; Greiser A; Paek MY; Choi BW; Kim TH
    Int J Cardiovasc Imaging; 2015 Jun; 31 Suppl 1():115-22. PubMed ID: 25634119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late gadolinium enhancement on cardiac magnetic resonance imaging is associated with coronary endothelial dysfunction in patients with dilated cardiomyopathy.
    Nakayama M; Yamamuro M; Takashio S; Uemura T; Nakayama N; Hirakawa K; Oda S; Utsunomiya D; Kaikita K; Hokimoto S; Yamashita Y; Morita Y; Kimura K; Tamura K; Tsujita K
    Heart Vessels; 2018 Apr; 33(4):393-402. PubMed ID: 29051976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between left ventricular diastolic function and ejection fraction in dilated cardiomyopathy using magnetic resonance imaging with late gadolinium enhancement.
    Nanjo S; Yoshikawa K; Harada M; Inoue Y; Namiki A; Nakano H; Yamazaki J
    Circ J; 2009 Oct; 73(10):1939-44. PubMed ID: 19729860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of combined late gadolinium enhancement on cardiovascular magnetic resonance and peak oxygen consumption in ambulatory patients with nonischemic dilated cardiomyopathy.
    Yamada T; Hirashiki A; Okumura T; Adachi S; Shimazu S; Shimizu S; Morimoto R; Takeshita K; Naganawa S; Kondo T; Murohara T
    J Card Fail; 2014 Nov; 20(11):825-32. PubMed ID: 25151210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of blood pressure response plus gadolinium enhancement in dilated cardiomyopathy.
    Tateishi E; Noguchi T; Goto Y; Morita Y; Ishibashi-Ueda H; Yamada N; Kanzaki H; Nishimura K; Miyamoto Y; Anzai T; Ogawa H; Yasuda S
    Heart; 2015 May; 101(10):774-80. PubMed ID: 25761994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy.
    Assomull RG; Prasad SK; Lyne J; Smith G; Burman ED; Khan M; Sheppard MN; Poole-Wilson PA; Pennell DJ
    J Am Coll Cardiol; 2006 Nov; 48(10):1977-85. PubMed ID: 17112987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging.
    Mark PB; Johnston N; Groenning BA; Foster JE; Blyth KG; Martin TN; Steedman T; Dargie HJ; Jardine AG
    Kidney Int; 2006 May; 69(10):1839-45. PubMed ID: 16508657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of endomyocardial biopsy in conjunction with cardiac magnetic resonance imaging to predict left ventricular reverse remodeling in idiopathic dilated cardiomyopathy.
    Ishii S; Inomata T; Fujita T; Iida Y; Ikeda Y; Nabeta T; Yanagisawa T; Naruke T; Mizutani T; Koitabashi T; Takeuchi I; Ako J
    Heart Vessels; 2016 Dec; 31(12):1960-1968. PubMed ID: 26920939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of late gadolinium enhancement is associated with increased left ventricular wall stress and mass in patients with non-ischaemic dilated cardiomyopathy.
    Alter P; Rupp H; Adams P; Stoll F; Figiel JH; Klose KJ; Rominger MB; Maisch B
    Eur J Heart Fail; 2011 Sep; 13(9):937-44. PubMed ID: 21803756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.
    Rudolph A; Abdel-Aty H; Bohl S; Boyé P; Zagrosek A; Dietz R; Schulz-Menger J
    J Am Coll Cardiol; 2009 Jan; 53(3):284-91. PubMed ID: 19147047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.